Tandem Diabetes Care (NASDAQ:TNDM) Stock Rating Reaffirmed by Morgan Stanley
MarketBeatMorgan Stanley reiterated an “equal weight” rating and set a $45.00 price target on shares of Tandem Diabetes Care in a research note on Monday.
Morgan Stanley reiterated an “equal weight” rating and set a $45.00 price target on shares of Tandem Diabetes Care in a research note on Monday.